Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1

REFERENCES

• van Hinsbergh VWM, Kooistra T, Scheffer MA, van Bockel JH, van Muijen GNP. Characteriza-tion and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothe-lial cells. Blood 1990; 75: 1490–7.
   Google Scholar
• Ivarsson ML, Holmdahl L, Falk P, Molne J, Risberg B. Characterization and fibrinolytic prop-erties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 1998; 58: 195— 203.
   Google Scholar
• Vipond MN, Whawell SA, Thompson JN, Dudley HA. Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet 1990; 335: 1120–2.
   PubMed Web of Science ®Google Scholar
• Holmdahl L, Al-Jabreen M, Risberg B. The role of fibrinolysis in the formation of adhesions. Wound Repair Regen 1994; 7: 171–6.
   Google Scholar
• Buckman RL, Sargent L, Gervin AS. The relationship of local depression of peritoneal fibrinolytic activity to adhesion formation. Clin Res 1975; 23: 15A.
   Google Scholar
• Raftery AT. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. An experimental study in the rat. Eur Surg Res 1981; 13: 397–401.
   PubMed Web of Science ®Google Scholar
• Vipond MN, Whawell SA, Thompson JN, Dudley HA. Effect of experimental peritonitis and ischae-mia on peritoneal fibrinolytic activity. Eur J Surg 1994; 160: 471–7.
   PubMedGoogle Scholar
• Scott-Coombes DM, Whawell SA, Thompson JN. The operative peritoneal fibrinolytic response to abdominal operation. Eur J Surg 1995; 161: 395–9.
   Google Scholar
• Holmdahl L, Eriksson E, al-Jabreen M, Risberg B. Fibrinolysis in human peritoneum during opera-tion. Surgery 1996; 119: 701–5.
   Google Scholar
• Holmdahl L, Eriksson E, Eriksson BI, Risberg B. Depression of peritoneal fibrinolysis during opera-tion is a local response to trauma. Surgery 1998; 123: 539–44.
   PubMed Web of Science ®Google Scholar
• Ivarsson M-L, Holmdahl L, Eriksson E, Soderberg R, Risberg B. Expression and kinetics of fibrinolytic components in plasma and perito-neum during abdominal surgery. Fibrinolysis 1998; 12: 61–7.
   Google Scholar
• Mignatti P, Rifkin DB, Welgus HG, Parks WC Proteinases and tissue remodelling, 2nd ed. New York: Plenum Press; 1996
   Google Scholar
• Chegini N, Gold LI, Williams RS, Masterson BJ. Localization of transforming growth factor beta isoforms TGF-beta 1, TGF-beta 2, and TGF-beta 3 in surgically induced pelvic adhesions in the rat. Obstet Gynecol 1994; 83: 449–54.
   PubMed Web of Science ®Google Scholar
• Roberts AB. Transforming growth factor-13: activ-ity and efficacy in animal models of wound healing. Wound Rep Reg 1995; 3: 408— 18.
   PubMedGoogle Scholar
• Clark DA, Coker R. Transforming growth factor-beta (TGF-beta). Int J Biochem Cell Biol 1998; 30: 293–8.
   PubMed Web of Science ®Google Scholar
• Holmdahl L, Bluhm R, Ivarsson M-L, Bergstrom M, Chegini N. Cellular localisation of the plasmin system and TGF-I3 in peritoneum in inflammatory and non-inflammatory conditions. Wound Repair Regen (In press)
   Google Scholar
• Idell S, Zwieb C, Boggaram J, Holiday D, Johnson AR, Raghu G. Mechanisms of fibrin formation and lysis by human lung fibroblasts: influence of TGF-beta and TNF-alpha. Am J Physiol 1992; 263 (4 Pt 1): L487–94.
   Google Scholar
• Idell S, James KK, Coalson JJ. Fibrinolytic activity in bronchoalveolar lavage of baboons with diffuse alveolar damage: trends in two forms of lung injury. Crit Care Med 1992; 20: 1431–40.
   Google Scholar
• Williams RS, Rossi AM, Chegini N, Schultz G. Effect of transforming growth factor beta on postoperative adhesion formation and intact peritoneum. J Surg Res 1992; 52: 65–70.
   PubMed Web of Science ®Google Scholar
• Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286–92.
   PubMed Web of Science ®Google Scholar
• Chegini N. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta). Eur J Surg Suppl 1997; (577): 17–23.
   Google Scholar
• Chegini N, Rong H, Bennett B, Stone IK. Peritoneal fluid cytokine and eicosanoid levels and their relation to the incidence of peritoneal adhesion [In Process Citation]. J Soc Gynecol Investig 1999; 6: 153–7 [MEDLINE record in process]
   PubMedGoogle Scholar
• Krause TJ, Katz D, Wheeler CJ, Ebner S, McKinnon RD. Increased levels of surgical adhesions in TGFbetal heterozygous mice. J Invest Surg 1999; 12: 31–8.
   Google Scholar
• Lucas PA, Warejcka DJ, Young HE, Lee BY. Formation of abdominal adhesions is inhibited by antibodies to transforming growth factor-beta 1. J Surg Res 1996; 65: 135–8.
   PubMed Web of Science ®Google Scholar
• Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS, et al. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 1996; 81: 3222— 30.
   PubMed Web of Science ®Google Scholar
• Dou Q, Williams RS, Chegini N. Expression of integrin messenger ribonucleic acid in human endometrium: a quantitative reverse transcription polymerase chain reaction study. Fertil Steril 1999; 71: 347–53.
   Google Scholar
• Petersen LC, Handest P, Brender J, Selmer J, Jorgensen M, Thorsen S. A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma using trinitrobenzoy-lated poly-D-lysine as a stimulator for plasmino-gen activation. Thromb Haemost 1987; 57: 205— 11.
   PubMed Web of Science ®Google Scholar
• Rougier JP, Guia S, Hagege J, Nguyen G, Ronco PM. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: tran-scriptional regulation by TGF-beta 1. Kidney Int 1998; 54: 87–98.
   Google Scholar
• Tietze L, Elbrecht A, Schauerte C, Klosterhalfen B, Amo-Takyi B, Gehlen J, et al. Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor betal (TGF-betal), tumor necrosis factor alpha (TNF-alpha) and interleukin lbeta (IL- lbeta). Thromb Haemost 1998; 79: 362–70.
   Google Scholar
• Bjorquist P, Ehnebom J, Inghardt T, Deinum J. Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator. Biochim Biophys Acta 1997; 1341: 87–98.
   PubMed Web of Science ®Google Scholar
• Treichel JA, Reddington M, Kreutzberg GW. Regulation of plasminogen activator inhibitor-1 mRNA accumulation by basic fibroblast growth factor and transforming growth factor-betal in cultured rat astrocytes. J Neurochem 1998; 71: 1944 — 52.
   Google Scholar
• Yoshiko B, Yamabe H, Osawa H, Okumura K. Regulation of tissue plasminogen activator pro-duction in cultured human fetal mesangial cells. Exp Nephrol 1998; 6: 508— 13.
   PubMedGoogle Scholar
• Gerwin BI, Keski-Oja J, Seddon M, Lechner JF, Harris CC. TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithe-lial cells. Am J Physiol 1990; 259 (4 Pt 1): L262–9.
   Google Scholar
• Holmdahl L, Falkenberg M, Ivarsson ML, Risberg B. Plasminogen activators and inhibitors in peritoneal tissue. Apmis 1997; 105: 25–30.
   PubMed Web of Science ®Google Scholar
• Holmdahl L. Making and covering of surgical footprints [comment] [see comments]. Lancet 1999; 353: 1456–7.
   PubMed Web of Science ®Google Scholar